In summary, the current study has demonstrated that DR4 expression is a poor prognostic factor in human lung adenocarcinoma and revealed a previously undiscovered anti-apoptotic function of DR4 in the induction of apoptosis by osimertinib and other EGFR-TKIs. Here, TNFRSF10A is linked to lung adenocarcinoma.